{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:50:14Z","timestamp":1761871814717,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clml.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T02:03:27Z","timestamp":1649901807000},"page":"e815-e825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit\/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5970-4692","authenticated-orcid":false,"given":"Justin J.","family":"Kuhlman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8582-1219","authenticated-orcid":false,"given":"Muhamad Alhaj","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-7357","authenticated-orcid":false,"given":"Karan","family":"Seegobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Wolcott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-5531","authenticated-orcid":false,"given":"Jonas","family":"Paludo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Inwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-5185","authenticated-orcid":false,"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-094X","authenticated-orcid":false,"given":"Han W.","family":"Tun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2022.04.009_bib0001","first-page":"421","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th edition)","author":"Swerdlow","year":"2017","journal-title":"IARC: Lyon"},{"key":"10.1016\/j.clml.2022.04.009_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12308-019-00342-2","article-title":"Leukemic presentation of high-grade B cell lymphoma with MYC and BCL2 rearrangement\u2014a series of two cases and review of literature","volume":"12","author":"Shahid","year":"2019","journal-title":"J Hematopathol"},{"key":"10.1016\/j.clml.2022.04.009_bib0003","article-title":"A leukemic presentation of a \u201ctriple-hit\u201d lymphoma","volume":"123","author":"Chen","year":"2014","journal-title":"Blood, The J Am Soc Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12881-017-0381-z","article-title":"BCL-2 and MYC gain\/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase","volume":"18","author":"Zou","year":"2017","journal-title":"BMC Med Genetics"},{"key":"10.1016\/j.clml.2022.04.009_bib0005","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-H odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the N ational C ancer D ata B ase from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2141.2003.04749.x","article-title":"Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation\u2013a population-based study of 1575 cases","volume":"124","author":"M\u00f8ller","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0007","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1080\/10428190903144667","volume":"50","author":"Sieniawski","year":"2009","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.clml.2022.04.009_bib0008","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1002\/cncr.27381","article-title":"Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era","volume":"118","author":"Takahashi","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2022.04.009_bib0009","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/01.pas.0000182405.65041.8b","article-title":"Bone marrow biopsy involvement by non-Hodgkin\u2019s lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens","volume":"29","author":"Arber","year":"2005","journal-title":"The Am J Surg Pathol"},{"key":"10.1016\/j.clml.2022.04.009_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jclinpath-2013-201520","article-title":"Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings","volume":"67","author":"Sovani","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clml.2022.04.009_bib0011","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.leukres.2013.05.016","article-title":"Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature","volume":"37","author":"Beltran","year":"2013","journal-title":"Leukemia Res"},{"key":"10.1016\/j.clml.2022.04.009_bib0012","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3109\/10428194.2011.574753","article-title":"Leukemic phase of follicular lymphomas: an atypical presentation","volume":"52","author":"Al-Nawakil","year":"2011","journal-title":"Leukemia & lymphoma"},{"issue":"12","key":"10.1016\/j.clml.2022.04.009_bib0013","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.22715","article-title":"Leukemic involvement is a common feature in mantle cell lymphoma","volume":"109","author":"Ferrer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2022.04.009_bib0014","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-007-0289-3","article-title":"Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature","volume":"86","author":"Grewal","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0015","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1080\/10428190410001723331","article-title":"The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients","volume":"45","author":"Matutes","year":"2004","journal-title":"Leukemia & lymphoma"},{"key":"10.1016\/j.clml.2022.04.009_bib0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bjh.12675","article-title":"Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis","volume":"164","author":"Sarkozy","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0017","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2141.2012.09209.x","article-title":"Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase","volume":"158","author":"Muringampurath-John","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.clml.2022.04.009_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4322\/acr.2016.027","article-title":"Diffuse large B-cell lymphoma presenting in the leukemic phase","volume":"6","author":"Pires","year":"2016","journal-title":"Autopsy & case reports"},{"key":"10.1016\/j.clml.2022.04.009_bib0019","article-title":"Diffuse large B-cell lymphoma in leukemic phase with flower cell morphology","volume":"123","author":"Wong","year":"2014","journal-title":"Blood, The J Am Soc Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0020","first-page":"149","article-title":"A rare case of de novo CD5+ diffuse large B-cell lymphoma in leukemic phase and positive for CD13","volume":"9","author":"Carulli","year":"2017","journal-title":"Hematol rep"},{"key":"10.1016\/j.clml.2022.04.009_bib0021","article-title":"Leukemic presentation of diffuse large B-cell lymphoma: an unusual pattern associated with splenic involvement","volume":"130","author":"Crane","year":"2017","journal-title":"Blood, The J Am Soc Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ccr3.1250","article-title":"Leukemic phase and CSF involvement of diffuse large B-cell lymphoma with a complex karyotype including a TP53 deletion","volume":"6","author":"Sinkoff","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.clml.2022.04.009_bib0023","first-page":"1","article-title":"Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia","volume":"12","author":"Balasubramanian","year":"2019","journal-title":"Clin Med Insights: Blood Disord"},{"key":"10.1016\/j.clml.2022.04.009_bib0024","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2022.04.009_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.04.009_bib0026","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00432-006-0188-3","article-title":"Non-Hodgkin lymphoma with t (14; 18): clonal evolution patterns and cytogenetic\u2013pathologic\u2013clinical correlations","volume":"133","author":"Aamot","year":"2007","journal-title":"J Cancer Res and Clin Oncol"},{"issue":"17","key":"10.1016\/j.clml.2022.04.009_bib0027","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1200\/JCO.2004.11.025","article-title":"Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas","volume":"22","author":"Be\u00e0","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2022.04.009_bib0028","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1054\/bjoc.2001.2164","article-title":"Loss of chromosome 11q21\u201323.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin\u2019s lymphoma","volume":"85","author":"Stokke","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clml.2022.04.009_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-76","article-title":"Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement","volume":"6","author":"Kim","year":"2013","journal-title":"J Hematol & Oncol"},{"key":"10.1016\/j.clml.2022.04.009_bib0030","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":"Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting","volume":"25","author":"Ponzoni","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2022.04.009_bib0031","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u2018cutaneous variant\u20191","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0032","first-page":"3884","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood, The J Am Socf Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0033","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/genes8040116","article-title":"The role of c-MYC in B-cell lymphomas: diagnostic and molecular aspects","volume":"8","author":"Nguyen","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.clml.2022.04.009_bib0034","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/cancers13133352","article-title":"Molecular update and evolving classification of large B-Cell lymphoma","volume":"13","author":"Onaindia","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clml.2022.04.009_bib0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/genes8040115","article-title":"Role of MYC in B cell lymphomagenesis","volume":"8","author":"Kora\u0107","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.clml.2022.04.009_bib0036","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncology"},{"key":"10.1016\/j.clml.2022.04.009_bib0037","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.04.009_bib0038","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.04.009_bib0039","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.04.009_bib0040","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Valera","year":"2013","journal-title":"haematologica"},{"key":"10.1016\/j.clml.2022.04.009_bib0041","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2022.04.009_bib0042","first-page":"2182","article-title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","volume":"127","author":"Savage","year":"2016","journal-title":"Blood, The J Am Soc Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0043","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjh.12982","article-title":"Double hit lymphoma: the MD A nderson C ancer C enter clinical experience","volume":"166","author":"Oki","year":"2014","journal-title":"Br J of Haematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2019-8-1","article-title":"Drug therapy for double-hit lymphoma","volume":"8","author":"Phuoc","year":"2019","journal-title":"Drugs in context"},{"key":"10.1016\/j.clml.2022.04.009_bib0045","first-page":"590","article-title":"How I treat double-hit lymphoma","volume":"130","author":"Friedberg","year":"2017","journal-title":"Blood, The J Am Soc Hematol"},{"key":"10.1016\/j.clml.2022.04.009_bib0046","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/hematology.2021000247","article-title":"Double-hit lymphoma: optimizing therapy","volume":"2021","author":"Dunleavy","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2022.04.009_bib0047","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S2352-3026(20)30366-5","article-title":"MATRix\u2013RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial","volume":"8","author":"Ferreri","year":"2021","journal-title":"The Lan Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:38:33Z","timestamp":1761871113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265022001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2152265022001215"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2022.04.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit\/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}